Pharmacy cops $15k hit on Vyvanse price cut

Nicholas O’Donoghue 11/12/2025

Community pharmacies left out of pocket, as the government secures $50 price reduction for ADHD medication Pharmacy owners are counting the cost of efforts to mitigate against supply shortages of attention deficit hyperactivity disorder (ADHD) medication, Vyvanse (lisdexamfetamine dimesilate), following a cut to the subsidised price. Speaking on ABC Radio Canberra, Pharmacy Guild of Australia

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Pharmacy cops $15k hit on Vyvanse price cut

Previous ParagonCare appoints new CFO

Next Cost of living hits hospital pharmacists hard: unions

MENU

ajp.com.au

Previous ParagonCare appoints new CFO

Next Cost of living hits hospital pharmacists hard: unions

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.